Kathleen N. Moore
- Reproductive Medicine top 0.05%
- Ovarian cancer diagnosis and treatment 303
- Obstetrics and Gynecology top 0.1%
- Endometrial and Cervical Cancer Treatments 109
- Oncology top 0.2%
- PARP inhibition in cancer therapy 123
- HER2/EGFR in Cancer Research 40
- Cancer Immunotherapy and Biomarkers 37
- Cancer Research top 1%
- Immunology top 2%
-
- Intraperitoneal and Appendiceal Malignancies 43
-
- Cervical Cancer and HPV Research 40
-
- Advanced Breast Cancer Therapies 39
- Co-authors
- Colin MartindaleMichael J. BirrerDavid M. O’MalleyCamille C. GundersonUrsula A. MatulonisRobert L. ColemanRobert S. MannelBradley J. Monk
- Journals
- Nature Communications (1 paper)Journal of Clinical Oncology (139 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Kathleen N. Moore
578 papers receiving 13.8k citations
Hit Papers
Peers
Comparison fields: 5 of 203
- Reproductive Medicine 4.8k
- Obstetrics and Gynecology 2.8k
- Oncology 6.2k
- Cancer Research 1.2k
- Immunology 1.5k
Countries citing papers authored by Kathleen N. Moore
This map shows the geographic impact of Kathleen N. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen N. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen N. Moore more than expected).
Fields of papers citing papers by Kathleen N. Moore
This network shows the impact of papers produced by Kathleen N. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen N. Moore. The network helps show where Kathleen N. Moore may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kathleen N. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 7 | |
| 3 | Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancerbreakdown → | 2024 | 58 |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 47 | |
| 11 | 2022 | 1 | |
| 12 | 2021 | 37 | |
| 13 | 2020 | 89 | |
| 14 | 2018 | 14 | |
| 15 | 2018 | 22 | |
| 16 | 2018 | 81 | |
| 17 | 2018 | 14 | |
| 18 | 2018 | 62 | |
| 19 | 2018 | 23 | |
| 20 | 1992 | 2 |
About Kathleen N. Moore
Kathleen N. Moore is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 612 papers that have together received 14.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (303 papers), PARP inhibition in cancer therapy (123 papers), Endometrial and Cervical Cancer Treatments (109 papers), Intraperitoneal and Appendiceal Malignancies (43 papers), Cervical Cancer and HPV Research (40 papers), HER2/EGFR in Cancer Research (40 papers), Advanced Breast Cancer Therapies (39 papers) and Cancer Immunotherapy and Biomarkers (37 papers). The work is most often cited by research in Reproductive Medicine (4.8k citations), Obstetrics and Gynecology (2.8k citations) and Oncology (6.2k citations). Kathleen N. Moore has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Colin Martindale, Michael J. Birrer, David M. O’Malley, Camille C. Gunderson, Ursula A. Matulonis, Robert L. Coleman, Robert S. Mannel, Bradley J. Monk, Theresa Thai and Joan L. Walker. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.